The role of ‘Maxar" in treatment of chronic viral hepatitides
The treatment of patients with chronic viral hepatitides is one of the important and unsolved issues. Infectious liver diseases characterized by liver failure with loss of its metabolic function, detoxification function, synthetic function, etc. Herbal medicines are widely use in treatment of liver failure caused by viral agents. These medicines do not impair liver function and characterized by absence of side effects with good tolerance. Good therapeutic effect of “Maxar” was shown in 26 patients with chronic viral hepatitides. “Maxar” improved patient’s biochemical status decreasing cytolysis and cholestasis syndromes, activating cell-mediated immunity and humoral immune response in patients with chronic hepatitis B, C, and B+C. Beneficial therapeutic effect of “Maxar” could be partially explained by activation of IgG and suppression of CD20+ lymphocytes.